Paper Details

  1. Home
  2. Paper Details

Efficacy of olanzapine in comparison with clozapine for treatment-resistant schizophrenia: evidence from a systematic review and meta-analyses.

Author: ElkisHelio, KayoMonica, MartinsCamila Bertini, SouzaJuliano S, TassellIvson

Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This systematic review compared clozapine with olanzapine in patients with TRS. Clozapine was significantly more efficacious than olanzapine in improving positive and negative symptoms in TRS patients.
Paper Details　
Original Abstract of the Article :
INTRODUCTION: Clozapine is considered the gold standard for the treatment of patients with treatment-resistant schizophrenia (TRS); however, randomized controlled trials (RCT) of olanzapine showed efficacy similar to clozapine in patients with TRS. METHODS: A systematic review was conducted compari...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1017/S1092852912000806

データ提供：米国国立医学図書館（NLM）

Olanzapine vs. Clozapine: A Comparative Study of Treatment-Resistant Schizophrenia

Schizophrenia, a complex mental illness, often presents significant challenges in treatment. This systematic review and meta-analysis compare the efficacy of olanzapine and clozapine in patients with treatment-resistant schizophrenia (TRS). The authors examine a collection of randomized controlled trials (RCTs) to determine which medication offers superior outcomes in this population.

Clozapine Emerges as a More Effective Treatment for TRS: A Meta-Analysis

The results suggest that clozapine is significantly more efficacious than olanzapine in improving both positive and negative symptoms in patients with TRS. The authors note that while olanzapine shows comparable effects on overall symptom severity, clozapine consistently outperforms it in reducing specific symptom domains.

Navigating Treatment Options for Schizophrenia: A Personalized Approach

This research highlights the importance of carefully considering treatment options for patients with TRS. While olanzapine may be effective in some cases, clozapine appears to be a superior choice for many patients. The choice of medication should be individualized based on the patient's specific needs and characteristics.

Dr. Camel's Conclusion

The sands of time can be unforgiving for those battling with schizophrenia. This research offers valuable insights into the relative efficacy of different treatment options, helping healthcare professionals guide patients towards the most effective path to recovery.

Date :
  1. Date Completed 2013-06-26
  2. Date Revised 2022-04-19
Further Info :

Pubmed ID

23253621

DOI: Digital Object Identifier

10.1017/S1092852912000806

Related Literature

Article Analysis
・Effective treatment of schizophrenia
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.